- Viral Genetics, Inc. (OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled to the general public initial findings of its ongoing Lyme Disease study. Viral Genetics initially unveiled its new model and early findings on Saturday, October 18th, at the 2008 International Lyme & Associated Diseases Society (ILADS) Scientific Session.
